We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Product Availability Update

Promega Manufacturing and Delivery Systems continue to be fully operational during the COVID-19 outbreak. Our teams are in regular contact with suppliers and distributors worldwide and are taking all steps necessary to address both demands for diagnostic tools and reliable delivery of all products as quickly as possible. Learn more

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Small Molecule Drug Discovery

The process of small molecule drug discovery can be complex and challenging.  A typical workflow begins with hit identification and assay development, and carries through to preclinical candidate selection. High-throughput screening of drug candidates plays in essential role in the drug discovery process.

Promega offers a comprehensive selection of tools to accelerate drug discovery, based on an innovative, sensitive bioluminescence platform.

 

 

Support for Contract Research Organizations (CROs)

Discover how Promega can help your CRO develop better solutions for your clients.

Learn More

NanoBRET™ Technology Powers Drug Discovery

Learn how Aurelia Bioscience used NanoBRET™ technology to measure kinase target engagement under more physiologically relevant conditions.

If you have questions or challenges with small molecule screening, we’re here to help.

Contact Us